Studies have shown that IL6 and IL10 can directly or indirectly stimulate NK cell activity, thus exerting anti-tumor effects (33, 34), which is consistent with previous studies indicating that NK cells are highly expressed in LCC and significantly correlated with the prognosis of patients (11). The gene discussed is IL10; the disease is leukoencephalopathy with calcifications and cysts.